# Kronos Worldwide Inc: financial statements, quarterly

KRO · NYSE · CIK 1257640 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kro.md) · [Financials](/companies/kro/financials.md) · [Filings](/companies/kro/filings.md) · [Insiders](/companies/kro/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kro/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [397](/filings/0001558370-24-014630.md) | [400 d](/filings/0001104659-26-025219.md) | [479](/filings/0001558370-25-006743.md) | [501](/filings/0001558370-25-010527.md) | [485](/filings/0001104659-25-107746.md) | [423 d](/filings/0001104659-26-025219.md) | [490](/filings/0001104659-26-056246.md) | [494](/filings/0001104659-26-091093.md) | [457](/filings/0001104659-25-107746.md) | [418 d](/filings/0001104659-26-025219.md) | [510](/filings/0001104659-26-056246.md) | [558](/filings/0001104659-26-091093.md) |
| Cost of revenue | $m | [363](/filings/0001558370-24-014630.md) | [345 d](/filings/0001104659-26-025219.md) | [407](/filings/0001558370-25-006743.md) | [400](/filings/0001558370-25-010527.md) | [384](/filings/0001104659-25-107746.md) | [337 d](/filings/0001104659-26-025219.md) | [383](/filings/0001104659-26-056246.md) | [432](/filings/0001104659-26-091093.md) | [410](/filings/0001104659-25-107746.md) | [422 d](/filings/0001104659-26-025219.md) | [427](/filings/0001104659-26-056246.md) | [455](/filings/0001104659-26-091093.md) |
| Gross profit | $m | [34.4](/filings/0001558370-24-014630.md) | [55.6 d](/filings/0001104659-26-025219.md) | [71.5](/filings/0001558370-25-006743.md) | [100](/filings/0001558370-25-010527.md) | [101](/filings/0001104659-25-107746.md) | [86.4 d](/filings/0001104659-26-025219.md) | [107](/filings/0001104659-26-056246.md) | [62.8](/filings/0001104659-26-091093.md) | [47.0](/filings/0001104659-25-107746.md) | [(3.6) d](/filings/0001104659-26-025219.md) | [83.3](/filings/0001104659-26-056246.md) | [103](/filings/0001104659-26-091093.md) |
| Selling, general and administrative | $m | [53.6](/filings/0001558370-24-014630.md) | [54.3 d](/filings/0001104659-26-025219.md) | [54.2](/filings/0001558370-25-006743.md) | [57.9](/filings/0001558370-25-010527.md) | [62.3](/filings/0001104659-25-107746.md) | [51.2 d](/filings/0001104659-26-025219.md) | [61.6](/filings/0001104659-26-056246.md) | [62.1](/filings/0001104659-26-091093.md) | [61.6](/filings/0001104659-25-107746.md) | [59.9 d](/filings/0001104659-26-025219.md) | [63.6](/filings/0001104659-26-056246.md) | [64.5](/filings/0001104659-26-091093.md) |
| Operating income | $m | [(25.3)](/filings/0001558370-24-014630.md) | [(5.7) d](/filings/0001104659-26-025219.md) | [19.5](/filings/0001558370-25-006743.md) | [35.9](/filings/0001558370-25-010527.md) | [38.9](/filings/0001104659-25-107746.md) | [28.6 d](/filings/0001104659-26-025219.md) | [38.4](/filings/0001104659-26-056246.md) | [7.4](/filings/0001104659-26-091093.md) | [(19.2)](/filings/0001104659-25-107746.md) | [(63.1) d](/filings/0001104659-26-025219.md) | [12.6](/filings/0001104659-26-056246.md) | [37.6](/filings/0001104659-26-091093.md) |
| Interest expense | $m | [4.3](/filings/0001558370-23-017424.md) | [4.3 d](/filings/0001558370-24-002607.md) | [9.2](/filings/0001558370-24-007346.md) | [9.8](/filings/0001558370-24-011359.md) | [11.8](/filings/0001104659-25-107746.md) | [12.1 d](/filings/0001104659-26-025219.md) | [11.6](/filings/0001104659-26-056246.md) | [12.8](/filings/0001104659-26-091093.md) | [14.1](/filings/0001104659-25-107746.md) | [14.5 d](/filings/0001104659-26-025219.md) | [14.3](/filings/0001104659-26-056246.md) | [14.2](/filings/0001104659-26-091093.md) |
| Income tax | $m | [(8.7)](/filings/0001558370-24-014630.md) | [(4.1) d](/filings/0001104659-26-025219.md) | [3.5](/filings/0001558370-25-006743.md) | [8.5](/filings/0001558370-25-010527.md) | [22.7](/filings/0001104659-25-107746.md) | [28.7 d](/filings/0001104659-26-025219.md) | [7.6](/filings/0001104659-26-056246.md) | [3.5](/filings/0001104659-26-091093.md) | [7.9](/filings/0001104659-25-107746.md) | [(5.5) d](/filings/0001104659-26-025219.md) | [2.8](/filings/0001104659-26-056246.md) | [7.7](/filings/0001104659-26-091093.md) |
| Net income | $m | [(20.4)](/filings/0001558370-24-014630.md) | [(5.3) d](/filings/0001104659-26-025219.md) | [8.1](/filings/0001558370-25-006743.md) | [19.5](/filings/0001558370-25-010527.md) | [71.8](/filings/0001104659-25-107746.md) | [(13.2) d](/filings/0001104659-26-025219.md) | [18.1](/filings/0001104659-26-056246.md) | [(9.2)](/filings/0001104659-26-091093.md) | [(37.0)](/filings/0001104659-25-107746.md) | [(82.8) d](/filings/0001104659-26-025219.md) | [(4.8)](/filings/0001104659-26-056246.md) | [15.2](/filings/0001104659-26-091093.md) |
| Diluted EPS | $ per share | [(0.18)](/filings/0001558370-24-014630.md) | not reported | [0.07](/filings/0001558370-25-006743.md) | [0.17](/filings/0001558370-25-010527.md) | [0.62](/filings/0001104659-25-107746.md) | not reported | [0.16](/filings/0001104659-26-056246.md) | [(0.08)](/filings/0001104659-26-091093.md) | [(0.32)](/filings/0001104659-25-107746.md) | not reported | [(0.04)](/filings/0001104659-26-056246.md) | [0.13](/filings/0001104659-26-091093.md) |
| Basic EPS | $ per share | [(0.18)](/filings/0001558370-24-014630.md) | not reported | [0.07](/filings/0001558370-25-006743.md) | [0.17](/filings/0001558370-25-010527.md) | [0.62](/filings/0001104659-25-107746.md) | not reported | [0.16](/filings/0001104659-26-056246.md) | [(0.08)](/filings/0001104659-26-091093.md) | [(0.32)](/filings/0001104659-25-107746.md) | not reported | [(0.04)](/filings/0001104659-26-056246.md) | [0.13](/filings/0001104659-26-091093.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [155](/filings/0001558370-23-017424.md) | [195](/filings/0001558370-25-002395.md) | [121](/filings/0001558370-24-007346.md) | [134](/filings/0001558370-24-011359.md) | [94.8](/filings/0001558370-24-014630.md) | [107](/filings/0001104659-26-025219.md) | [20.5](/filings/0001558370-25-006743.md) | [18.9](/filings/0001558370-25-010527.md) | [27.7](/filings/0001104659-25-107746.md) | [33.2](/filings/0001104659-26-091093.md) | [25.7](/filings/0001104659-26-056246.md) | [26.6](/filings/0001104659-26-091093.md) |
| Current assets | $m | [1,000](/filings/0001558370-23-017424.md) | [1,117](/filings/0001558370-25-002395.md) | [985](/filings/0001558370-24-007346.md) | [987](/filings/0001558370-24-011359.md) | [1,068](/filings/0001558370-24-014630.md) | [1,105](/filings/0001104659-26-025219.md) | [1,126](/filings/0001558370-25-006743.md) | [1,088](/filings/0001558370-25-010527.md) | [1,070](/filings/0001104659-25-107746.md) | [995](/filings/0001104659-26-091093.md) | [989](/filings/0001104659-26-056246.md) | [943](/filings/0001104659-26-091093.md) |
| Total assets | $m | [1,716](/filings/0001558370-23-017424.md) | [1,838](/filings/0001558370-25-002395.md) | [1,679](/filings/0001558370-24-007346.md) | [1,657](/filings/0001558370-24-011359.md) | [1,922](/filings/0001558370-24-014630.md) | [1,914](/filings/0001104659-26-025219.md) | [1,946](/filings/0001558370-25-006743.md) | [1,940](/filings/0001558370-25-010527.md) | [1,910](/filings/0001104659-25-107746.md) | [1,817](/filings/0001104659-26-091093.md) | [1,798](/filings/0001104659-26-056246.md) | [1,744](/filings/0001104659-26-091093.md) |
| Current liabilities | $m | [256](/filings/0001558370-23-017424.md) | [371](/filings/0001558370-25-002395.md) | [268](/filings/0001558370-24-007346.md) | [273](/filings/0001558370-24-011359.md) | [398](/filings/0001558370-24-014630.md) | [477](/filings/0001104659-26-025219.md) | [430](/filings/0001558370-25-006743.md) | [390](/filings/0001558370-25-010527.md) | [279](/filings/0001104659-25-107746.md) | [369](/filings/0001104659-26-091093.md) | [311](/filings/0001104659-26-056246.md) | [286](/filings/0001104659-26-091093.md) |
| Long-term debt | $m | [423](/filings/0001558370-23-017424.md) | [441](/filings/0001558370-25-002395.md) | [427](/filings/0001558370-24-007346.md) | [424](/filings/0001558370-24-011359.md) | [470](/filings/0001558370-24-014630.md) | [429](/filings/0001104659-26-025219.md) | [476](/filings/0001558370-25-006743.md) | [501](/filings/0001558370-25-010527.md) | [626](/filings/0001104659-25-107746.md) | [557](/filings/0001104659-26-091093.md) | [603](/filings/0001104659-26-056246.md) | [570](/filings/0001104659-26-091093.md) |
| Current portion of debt | $m | [0.7](/filings/0001558370-23-017424.md) | not reported | not reported | not reported | [83.9](/filings/0001558370-24-014630.md) | [78.3](/filings/0001104659-26-025219.md) | [81.2](/filings/0001558370-25-006743.md) | [87.9](/filings/0001558370-25-010527.md) | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [833](/filings/0001558370-24-014630.md) | [808](/filings/0001104659-26-025219.md) | [774](/filings/0001558370-25-010527.md) | [775](/filings/0001104659-25-107746.md) | [847](/filings/0001104659-25-107746.md) | [817](/filings/0001104659-26-091093.md) | [847](/filings/0001104659-26-091093.md) | [847](/filings/0001104659-26-091093.md) | [805](/filings/0001104659-25-107746.md) | [751](/filings/0001104659-26-091093.md) | [745](/filings/0001104659-26-091093.md) | [751](/filings/0001104659-26-091093.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [17.7 d](/filings/0001558370-24-014630.md) | [64.4 d](/filings/0001104659-26-025219.md) | [(43.3)](/filings/0001558370-25-006743.md) | [38.2 d](/filings/0001558370-25-010527.md) | [28.3 d](/filings/0001104659-25-107746.md) | [49.3 d](/filings/0001104659-26-025219.md) | [(102)](/filings/0001104659-26-056246.md) | [20.7 d](/filings/0001104659-26-091093.md) | [(7.9) d](/filings/0001104659-25-107746.md) | [92.1 d](/filings/0001104659-26-025219.md) | [(51.3)](/filings/0001104659-26-056246.md) | [53.3 d](/filings/0001104659-26-091093.md) |
| Capital expenditure | $m | [8.2 d](/filings/0001558370-24-014630.md) | [5.3 d](/filings/0001104659-26-025219.md) | [4.7](/filings/0001558370-25-006743.md) | [3.4 d](/filings/0001558370-25-010527.md) | [9.1 d](/filings/0001104659-25-107746.md) | [12.3 d](/filings/0001104659-26-025219.md) | [12.0](/filings/0001558370-25-006743.md) | [11.2 d](/filings/0001558370-25-010527.md) | [9.5 d](/filings/0001104659-25-107746.md) | [10.2 d](/filings/0001104659-26-025219.md) | not reported | not reported |
| Dividends paid | $m | [21.8 d](/filings/0001558370-24-014630.md) | [21.9 d](/filings/0001104659-26-025219.md) | [21.9](/filings/0001558370-25-006743.md) | [21.8 d](/filings/0001558370-25-010527.md) | [5.8 d](/filings/0001104659-25-107746.md) | [5.7 d](/filings/0001104659-26-025219.md) | [5.8](/filings/0001104659-26-056246.md) | [5.7 d](/filings/0001104659-26-091093.md) | [5.8 d](/filings/0001104659-25-107746.md) | [5.7 d](/filings/0001104659-26-025219.md) | [5.8](/filings/0001104659-26-056246.md) | [5.7 d](/filings/0001104659-26-091093.md) |
| Share repurchases | $m | [0.0 d](/filings/0001558370-24-014630.md) | [0.0 d](/filings/0001104659-26-025219.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [116](/filings/0001558370-23-017424.md) | [115](/filings/0001558370-24-007346.md) | [115](/filings/0001558370-24-011359.md) | [115](/filings/0001558370-24-014630.md) | [115](/filings/0001558370-25-006743.md) | [115](/filings/0001558370-25-010527.md) | [115](/filings/0001104659-25-107746.md) | [115](/filings/0001104659-26-056246.md) | [115](/filings/0001104659-26-091093.md) | [115](/filings/0001104659-25-107746.md) | [115](/filings/0001104659-26-056246.md) | [115](/filings/0001104659-26-091093.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 115,097,516 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001104659-26-091093.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.